Last reviewed · How we verify
Structolipid
At a glance
| Generic name | Structolipid |
|---|---|
| Also known as | control |
| Sponsor | Huazhong University of Science and Technology |
| Modality | Small molecule |
| Therapeutic area | Metabolic |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Safely and Efficacy of ClinOleic-based Lipid Parenteral Nutrition (PHASE1)
- Omega-3 Fatty Acid-Based Parenteral Nutrition Improves Postoperative Recovery for Cirrhotic Patients With Liver Cancer (PHASE4)
- Application of n-3 Fatty to Patient of Jaundice
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |